IDO1 can suppress the activation of CD8+ T cells and NK cells within the tumor microenvironment while simultaneously enhancing the recruitment of MDSCs, thereby inhibiting the replication of HSV-1 [52]. This evidence concerns the gene CD8A and neoplasm.